[
    [
        {
            "time": "2018-03-20",
            "original_text": "明日最具投资机会六大牛股一览（3月20日）",
            "features": {
                "keywords": [
                    "投资机会",
                    "牛股"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "明日最具投资机会六大牛股一览（3月20日）",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-03-20",
            "original_text": "合作上海交大 布局生物制药",
            "features": {
                "keywords": [
                    "合作",
                    "上海交大",
                    "生物制药"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "合作上海交大 布局生物制药",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-03-20",
            "original_text": "[强烈推荐评级]凯莱英(002821)事件点评：生物药研发服务布局初步落地 公司四大战略规划稳步推进未来3年高增速可期",
            "features": {
                "keywords": [
                    "凯莱英",
                    "生物药",
                    "研发服务",
                    "战略规划",
                    "高增速"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[强烈推荐评级]凯莱英(002821)事件点评：生物药研发服务布局初步落地 公司四大战略规划稳步推进未来3年高增速可期",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-03-20",
            "original_text": "【天风Morning Call】晨会集萃20180320",
            "features": {
                "keywords": [
                    "天风Morning Call",
                    "晨会集萃"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【天风Morning Call】晨会集萃20180320",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 3
            }
        },
        {
            "time": "2018-03-20",
            "original_text": "凯莱英点评报告:校企共建联合实验室,进军大分子药物领域",
            "features": {
                "keywords": [
                    "凯莱英",
                    "校企共建",
                    "联合实验室",
                    "大分子药物"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "凯莱英点评报告:校企共建联合实验室,进军大分子药物领域",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-03-20",
            "original_text": "医药行业中国研发外包行业迎来高景气周期(系列二):基于12家CRO、CDMO企业的比较分析",
            "features": {
                "keywords": [
                    "医药行业",
                    "研发外包",
                    "高景气周期",
                    "CRO",
                    "CDMO"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业中国研发外包行业迎来高景气周期(系列二):基于12家CRO、CDMO企业的比较分析",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 9,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        }
    ]
]